Literature DB >> 15808373

Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.

Nabil Mtiraoui1, Lobna Borgi, Sondes Hizem, Brahim Nsiri, Ramzi R Finan, Jean-Christophe Gris, Wassim Y Almawi, Touhami Mahjoub.   

Abstract

OBJECTIVE: We assessed the prevalence of inherited (FV-Leiden and PRT G20210A), and acquired (anti-PL antibodies) risk factors among habitual aborters in Tunisia. STUDY
DESIGN: We studied prospectively 146 patients with > or =3 consecutive early, late, or early-late recurrent pregnancy losses, together with 99 age-matched controls. Anticardiolipin antibodies (ACL), lupus anticoagulant (LA), and APC resistance (APCR) were detected by ELISA, dilute Russell Viper Venom Time (dRVVT), and coagulation tests, respectively, and FV-Leiden and PRT G20210A genotypes were assessed by PCR.
RESULTS: Anti-PL antibody frequencies were 45 and 9% among patients and controls, respectively (P < 0.001), with positive LA only (P = 0.004), or combined elevated ACL-positive LA being consistently higher (P < 0.001) among patients than controls. FV-Leiden (20.54% versus 6.06%), but not PRT G20210A (2.74% versus 4.04%) was significantly higher in patients versus controls. Among LA-positive cases higher prevalence of G/A (14/146 versus 1/99) and A/A genotypes (4/146 versus 0/99) were seen, and among ACL-positive cases higher prevalence of G/A (10/146 versus 0/99) and A/A genotypes (2/146 versus 0/99) were recorded.
CONCLUSIONS: Anti-PL antibodies and FV-Leiden, but not PRT G20210A, are associated with recurrent idiopathic pregnancy losses in Tunisian women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808373     DOI: 10.1016/j.ejogrb.2004.07.003

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.

Authors:  Wassim Y Almawi; Sose H Keleshian; Lobna Borgi; Naglaa A Fawaz; Nisreen Abboud; Nabil Mtiraoui; Touhami Mahjoub
Journal:  J Thromb Thrombolysis       Date:  2005-12       Impact factor: 2.300

2.  Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-11-28       Impact factor: 2.576

3.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

Review 4.  Factor V Leiden 1691G > A mutation and the risk of recurrent pregnancy loss (RPL): systematic review and meta-analysis.

Authors:  Mohammad Masoud Eslami; Majid Khalili; Mina Soufizomorrod; Saeid Abroun; Bahman Razi
Journal:  Thromb J       Date:  2020-06-24

5.  Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice.

Authors:  Aviva Katzav; Nikolaos C Grigoriadis; Tania Ebert; Olga Touloumi; Miri Blank; Chaim G Pick; Yehuda Shoenfeld; Joab Chapman
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

6.  Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population.

Authors:  Samieh Karimi; Majid Yavarian; Azadeh Azinfar; Minoo Rajaei; Maryam Azizi Kootenaee
Journal:  Iran J Reprod Med       Date:  2012-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.